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bone, CIRS) which are at isocenter and irradiated with 
therapeutic protons beams. The tissue equivalence of the 
irradiated materials for neutron doses (per incident proton) 
and energy spectra has previously been established with 
Geant4 simulations. Pulse shape discrimination is used to 
classify each detected pulse as either a neutron or a gamma 
ray, which allows selective analysis of the neutron and 
gamma ray spectra. Data are acquired using a digital 
measurement system based on a CAEN DT5720 waveform 
digitizer (12 bit, 250 MHz). The response of the scintillators is 
also simulated using a detection post-processor distributed 
with a modified version of MCNPX (PoliMi code). To validate 
the code, the total simulated neutron pulse height 
distributions scaled to the absolute fluence recorded during 
the measurements is compared with the measured 
distributions from the scintillators. 
 
Results: There was good agreement (within 10%) of neutron 
dose and energy spectra for investigated tissue equivalent 
materials when compared to ICRP human tissues. So far 
measurements have been performed at three different 
proton treatment centers and measurements at two 
additional centers are planned, thus testing the system on a 
range of contemporary proton beam accelerators and beam 
delivery systems. Good agreement was found between the 
detector responses and Monte Carlo simulations. Using 
MCPNX, it was shown that the secondary neutron field can be 
separated into two distinct components; an isotropic, low-
energy component and a forward-directed, high-energy 
component. 
 
Conclusion: The neutron dosimetry system is applicable to 
any proton facility and will be valuable for prospective data 
collection of neutron doses and second cancer risk 
evaluation, thus establishing the dosimetric basis for a 
prospective clinical data base for paediatric proton patients. 
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Purpose or Objective: The study presented here is three-
part work whose primary aims were to determine a) the 
properties of the scattered radiation responsible for out-of-
field doses b) the out-of-field radiation doses at varying 
distances from the primary beam, and c) the impact of these 
doses to biological response of in-vitro cells. 
 
Material and Methods: We developed a purpose-designed 
water phantom to study out-of-field radiation. The phantom 
consists of seven dual-purpose inserts that can be used to 
measure doses and to assess radiobiological effects at the 
same measuring points. The photon (6 MV) energy spectra 
were calculated at 5 unique positions (at depths of 0.5 1.6, 
4, 6, 8, and 10 cm) along the central beam axis (CAX) and at 
six different off-axis distances. To gain a better 
understanding of out-of-field doses, we measure the 
individual contribution of photons and neutrons to the total 
out-of-field dose for 6 MV and 20MV photons at open beam. 
Radiation doses were measured at 6 separate points in the 
phantom with TLD 100, TLD 600, TLD 700, and Gafchromic 
EBT films. Cells from the human breast cancer line MDA-MB-
231 were inserted in a water phantom and irradiated at CAX 
and off-axis distance, at varying doses (1.5, 2.0, 2.5, 3.0 Gy). 
Survival fraction, number of DNA double strand-breaks (DNA 
DSBs), and cleaved PARP levels were determined by 
clonogenic assay and flow cytometry. 
 
Results: Measured Monte Carlo simulations showed that mean 
radiation energy levels drop rapidly beyond the edge of the 6 
MV photon beam field (Table 1). Simulations showed that the 
energy level actually increased slightly in some cases as the 
distance from the field edge increased. At a prescribed dose 
of 75 Gy to the isocentre, the measured photon dose level in 
the close-to-field area could reach up to 2.0-2.5Gy for 6MV 
and 1.5-2.0Gy for 20MV. Although the dose decreased rapidly 
as the distance from the CAX increased, even distant doses 
could reach several cGy when photons were used (Fig. 1). 
The neutron dose for 20 MV photons at a distance of 25 cm 
from the isocentre was 3.5 mSv/Gy. A slight non-significant 
decrease of 3-5% in cell SF was observed in cells irradiated 
outside the primary field. 
 
 
 
 
Conclusion: The dose levels measured in this study strongly 
suggest that out-of-field doses (especially for 20 MV) should 
be taken in consideration to obtain radiation protection of 
patients, as these dose levels could increase second cancer 
risk. Scattered irradiation appears to induce an in vitro 
biological response on out-of-field cells. 
 
Poster: Physics track: Treatment plan optimisation: 
algorithms  
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Purpose or Objective: Treatment plans for head and neck 
(H&N) cancer are highly complex due to multiple dose 
prescription levels and numerous organs at risk (OAR) close to 
the target. The plan quality is inter-planner dependent since 
it is dependent on the skills and experience of the 
dosimetrist. This study presents a blinded clinical comparison 
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of automatic (AU) and manual (MA) generated H&N VMAT 
plans created for clinical use. 
 
Material and Methods: All patients (n=30) referred to 
curative H&N radiotherapy in August and September 2015 
were planned with a MA and AU VMAT plan in Pinnacle 
version 9.10. Half of the tumours were located in the pharynx 
(15) and the rest were mixed between larynx (4), oral cavity 
(3), salivary glands (2), thyroid gland and unknown primary 
(4). The plans followed national guidelines, and planning 
techniques were blinded before clinical evaluation of senior 
oncologists. The MA plans were optimized according to 
standard clinical practice. The AU plans were created by the 
Autoplan software available in the Pinnacle planning system. 
After AU optimisation, slight manual fine-tuning of the plans 
was performed. To supplement the clinical evaluation the 
operator time for the dosimetrist was recorded along with 
DVH parameters and the global detector pass rate (3% and 
3mm) of the delivered plans on an ArcCheck phantom. All 
statistical analyses were performed with a paired Wilcoxon-
signed rank test. 
 
Results: In 29/30 plans, the AU plan was chosen for clinical 
application (p<0.001). In terms of DVH parameters similar 
target coverage was obtained between the two planning 
methods. As seen in the table, mean OAR doses were 
significantly reduced in the AU plans for all organs. The mean 
reduction ranged from 0.5 Gy for the entire patient to 6.5 Gy 
for the contralateral submandibular gland. Differences in DVH 
showed significant AU superiority in the dose range 10 Gy to 
45 Gy for all organs (Mean DVH example shown in figure). The 
only manual plan selected for clinical use was a thyroid 
cancer plan involving level VII lymph nodes and therefore 
included a large volume of the lung, which had a lower lung 
dose in the manual plan. The AU plans were more modulated 
as illustrated by the increase in MUs, which might cause the 
reduced, but still clinically acceptable, pass rate of 97.7% in 
ArcCheck measurements. The increased beam-on time of 4 
sec is clinically unimportant. Mean operator time spent on MA 
plans was more than twice that of AU plans. The target 
homogeneity, conformity and dose fall off were all superior 
in the AU plans. 
 
 
 
 
Conclusion: All AU and MA plans were of acceptable clinical 
quality, however, AU plans resulted in reduced doses to all 
OAR and required less operator time in the planning process. 
AU plans were almost consistently preferred by senior head 
and neck cancer specialists. The dosimetric superiority of the 
AU plans was evident.  
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Purpose or Objective: RapidPlan (Varian Medical Systems) is 
a knowledge-based planning solution based on a model 
derived from a library of previous treatment plans. The 
model utilizes the geometric features and associated 
dosimetry of these plans to predict a range of achievable 
dose volume histograms (DVHs) for each organ at risk (OAR) 
of a new patient. RapidPlan (RP) drives the VMAT or IMRT 
optimization process by placing a line of optimization 
objectives along the lower boundary of the DVH prediction 
range. Planning inconsistencies may lead to sub-optimal plans 
in the model, which can be identified as dosimetric outliers. 
Outlier cleaning is advised, however this is time consuming 
and often subjective. We examined the effect of model 
cleaning and increasing numbers of dosimetric outliers in a 
model library, on RP plan quality. 
 
Material and Methods: 70 head and neck cancer treatment 
plans (planned consistently using the same departmental 
objective priorities) were used to populate uncleaned 
ModelUC. Statistical metrics provided by RP were used to 
identify geometric/dosimetric outliers in ModelUC which 
were then visually assessed and, if appropriate, removed to 
create cleaned ModelC. The last 5-40 patients (increments of 
5) of ModelC were then re-planned with no attempt to spare 
the salivary glands, and afterward re-introduced to ModelC, 
creating Model5-40. All models were used to create plans for 
a 10 patient evaluation group. Although RP can generate OAR 
objective priorities, for this study, the same standard 
priorities were used as for the plans in ModelUC. Plans were 
compared on the basis of generated prediction ranges, 
boost/elective target volume homogeneity index (HIB/HIE), 
mean dose to the oral cavity (OC) and to composite 
structures comprising the salivary glands (compsal) and 
swallowing structures (compswal). 
 
